脑、肾等器官结构与功能检测-.pptVIP

* 据卫生部心血管病防治研究中心发布的《中国心血管病报告2005》报道，冠心病已经成为我国人群的重要死因。统计学显示，近20年来，我国的心血管病死亡率呈上升趋势，其中，脑血管病为第一死亡原因，冠心病紧随其后，位居第二。在2004年城市居民总心脏病死亡中，冠心病死亡占48%。报告还同时指出，在我国，高血压是冠心病最重要危险因素，高血压导致心血管病的相对危险高达3-4倍，在总的心血管病事件中，23.7%的急性冠心病事件归因于高血压。因此，治疗高血压是减少冠心病事件的重要措施。 * 据卫生部心血管病防治研究中心发布的《中国心血管病报告2005》报道，冠心病已经成为我国人群的重要死因。统计学显示，近20年来，我国的心血管病死亡率呈上升趋势，其中，脑血管病为第一死亡原因，冠心病紧随其后，位居第二。在2004年城市居民总心脏病死亡中，冠心病死亡占48%。报告还同时指出，在我国，高血压是冠心病最重要危险因素，高血压导致心血管病的相对危险高达3-4倍，在总的心血管病事件中，23.7%的急性冠心病事件归因于高血压。因此，治疗高血压是减少冠心病事件的重要措施。 * NOTES FOR PRESENTERS: Definitions In this guideline the following definitions are used: Stage 1 hypertension Clinic blood pressure is 140/90?mmHg or higher and subsequent ambulatory blood pressure monitoring (ABPM) daytime average or home blood pressure monitoring (HBPM) average blood pressure is 135/85?mmHg or higher. Stage 2 hypertension Clinic blood pressure is 160/100?mmHg or higher and subsequent ABPM daytime average or HBPM average blood pressure is 150/95?mmHg or higher. Severe hypertension Clinic systolic blood pressure is 180?mmHg or higher or clinic diastolic blood pressure is 110?mmHg or higher. Additional information: ABPM – ambulatory blood pressure monitoring HBPM – home blood pressure monitoring * * NOTES FOR PRESENTERS. Key priority recommendations are identified with [KPI] in these notes. Step 3 treatment Before considering step?3 treatment, review medication to ensure step 2 treatment is at optimal or best tolerated doses. [new 2011] [1.6.16] If treatment with three drugs is required, the combination of ACE inhibitor (or angiotensin-II receptor blocker), calcium-channel blocker and thiazide-like diuretic should be used. [2006] [1.6.17] Step 4 treatment Regard clinic blood pressure that remains higher than 140/90?mmHg after treatment with the optimal or best tolerated doses of an ACE inhibitor or an ARB plus a CCB plus a diuretic as resistant hypertension, and consider adding a fourth antihypertensive drug and/or seeking expert advice. [new 2011] [1.6.18] For treatment of